<DOC>
	<DOCNO>NCT00224705</DOCNO>
	<brief_summary>The purpose study improve survival rate patient acute fulminant hepatitis treatment MARS® extra-corporal liver-purification system : 1 . Reducing number patient die graft available 2 . Increasing chance survival without liver transplant 3 . Reducing pre- post-operative mortality transplant patient</brief_summary>
	<brief_title>The MARS® Albumin Dialysis System Patients With Fulminant Subfulminant Hepatic Failure</brief_title>
	<detailed_description>Patients fulminant subfulminant hepatitis either indication relative contraindication liver transplantation , randomize two group : 1 . A group treat conventional medical intensive treatment ( include hemodialysis technique , continuous veno-venous hemofiltration hemodiafiltration , necessary ) gold standard surgical treatment ( liver transplantation ) compare 2 . A group receiving , addition conventional medical intensive treatment , albumin dialysis use MARS device gold standard surgical treatment ( liver transplantation ) .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Liver Failure</mesh_term>
	<criteria>Patients severe subsevere hepatitis , indication contraindication liver transplantation Sepsis severe control Haemorrhage activates control Clinical Obviousness disseminate intravascular coagulation Severe Pathology cardiopulmonary ( NYHA &gt; = 2 ) Pregnancy , breast feeding Average blood Pressure &lt; 40 mmHg 10 minute spite support inotrope Nonhepatic coma origin Cholestases extrahepatitic Antecedents heavy surgery 4 previous week surgical problem unsolved Absolute counterindication hepatic transplantation ( extra Neoplasia hepatic evolutionary , irreversible cerebral Attack , irreversible multivisceral Failure , visceral tare contraindicate transplantation ) Positive serology HIV Hepatic Demonstrations malignant hemopathies Participation another therapeutic test 4 previous week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2007</verification_date>
	<keyword>Albumin dialysis</keyword>
	<keyword>MARS system</keyword>
	<keyword>Extracorporeal artificial liver support</keyword>
	<keyword>Fulminant hepatitis</keyword>
	<keyword>Subfulminant hepatitis</keyword>
	<keyword>Acute liver failure</keyword>
</DOC>